Zobrazeno 1 - 10
of 13
pro vyhledávání: ''
Autor:
Sonica Sachdeva Batra, Suresh Kankanwadi, A. Mukhopadhyay, Auro Viswabandya, Sandip Shah, Luis Lopez-Lazaro, Rajnish Vasant Nagarkar, Alok Srivastava
Publikováno v:
Journal of Global Oncology
Journal of Global Oncology, Vol 5, Pp 1-13 (2019)
Journal of Global Oncology, Vol 5, Pp 1-13 (2019)
PURPOSE We sought to compare the pharmacokinetics (PKs) of DRL-rituximab (DRL_RI; potential biosimilar) and innovator rituximab MabThera (Roche, Grenzach-Wyhlen, Germany; reference medicinal product [RMP]) in patients with diffuse large B-cell lympho
Autor:
Robert Bett Yatich, Bonginkosi Shoba, Angela McLigeyo, NA Othieno-Abinya, Mohammed S. Ezzi, EO Amayo, Peter Oyiro
Publikováno v:
Journal of Global Oncology
Journal of Global Oncology, Vol 5, Pp 1-6 (2019)
Journal of Global Oncology, Vol 5, Pp 1-6 (2019)
PURPOSE To determine the prevalence, predictors, and/or risk factors of chemotherapy-induced peripheral neuropathy in patients undergoing chemotherapy with cisplatin at Kenyatta National Hospital, Nairobi, Kenya. METHODS This was a cross-sectional an
Autor:
Márcia Silveira Graudenz, Alvaro Henrique Ingles Garces, Andreia Cristina de Melo, Pedro Duarte Abreu, Carlos Jose C Andrade, Mariana R Monteiro, Ana Paula Stramosk, Rafael C Coelho
Publikováno v:
Journal of Global Oncology
Repositório Institucional da UFRGS
Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
Journal of Global Oncology, Vol 5, Pp 1-8 (2019)
Repositório Institucional da UFRGS
Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
Journal of Global Oncology, Vol 5, Pp 1-8 (2019)
PURPOSE Gastric cancer (GC) is the fourth most common cancer and the second leading cause of cancer death worldwide. Platinum agents and fluoropyrimidines are the main compounds used in the first-line setting for advanced GC. Given the activity of fl
Autor:
Marwan Ghosn, Roland Eid, Emad Hamada, Hamdy Abdel Azim, Jamal Zekri, Mubarak Al-Mansour, Mohammed Jaloudi, Fadi Nasr, Hassan Errihani, Adda Bounedjar, Amel Mezlini, Hamouda Boussen, Joseph Kattan, Fadi El Karak, Fadi Farhat, on behalf of the Africa Middle East Cancer Intergroup
Publikováno v:
Journal of Global Oncology
Journal of Global Oncology, Vol 5, Pp 1-10 (2019)
Journal of Global Oncology, Vol 5, Pp 1-10 (2019)
PURPOSE Sunitinib offers improved efficacy for patients with metastatic renal cell carcinoma (mRCC). To provide better disease management in the Middle East, we studied its use in mRCC in real-life practice in this region. MATERIAL AND METHODS Patien
Publikováno v:
Journal of Global Oncology
Journal of Global Oncology, Vol 4, Pp 1-7 (2018)
Journal of Global Oncology, Vol 4, Pp 1-7 (2018)
Purpose This study aims to evaluate trends in the increasing costs of oncology drugs procured by the Lebanese Ministry of Public Health (MOPH) between 2014 and 2016 and to assess the impact of the introduction in mid-2015 of new immunotherapy drugs f
Autor:
Fredrick Chite Asirwa, Patrick J. Loehrer, Gabriel Kigen, Matthew Robert Strother, Alfred Keter, Paul Waako, Naftali Busakhala
Publikováno v:
Journal of Global Oncology
Journal of Global Oncology, Vol 4, Pp 1-9 (2018)
Journal of Global Oncology, Vol 4, Pp 1-9 (2018)
Purpose Kaposi’s sarcoma (KS) is a spindle cell tumor resulting from growth dysregulation in the setting of infection with human herpes virus-8 (also called KS herpes virus). Advanced KS is characterized by poor responses to antiretroviral therapy
Autor:
Manuel Caitano Maia, Allan Andresson Lima Pereira, Liana Valente Lage, Carlos Dzik, Natalia Moreno Perez Fraile, Guilherme Konishi Kudo, Diogo Assed Bastos, Romualdo Barroso-Sousa, Victor Van Vaisberg
Publikováno v:
Journal of Global Oncology
Journal of Global Oncology, Vol 4, Pp 1-9 (2017)
Journal of Global Oncology, Vol 4, Pp 1-9 (2017)
Purpose Limited data are available about the tolerability and clinical outcomes of elderly patients with metastatic castration-resistant prostate cancer (mCRPC) who are treated with docetaxel. We evaluated the efficacy and safety of docetaxel as firs
Autor:
Cheng Tzu Yen, Gilberto de Castro, Diogo Assed Bastos, Eduardo Perrone, Deise Uema, Denyei Nakazato
Publikováno v:
Journal of Global Oncology, Vol 4, Pp 1-4 (2017)
Journal of Global Oncology
Journal of Global Oncology
G6PD is the most common enzymatic deficiency in humans,1,2 affecting approximately 5% of the world's population.3 Currently, there are more than 180 reported genetic variants of G6PD and its expression can vary from a mild (class V) to a severe defic
Autor:
Daya Nand Sharma, Pavnesh Kumar, Goura Kishor Rath, Narayan Adhikari, K.P. Haresh, Subhash Gupta, Bhanu Prasad Venkatesulu, Rambha Pandey
Publikováno v:
Journal of Global Oncology
Journal of Global Oncology, Vol 4, Pp 1-4 (2016)
Journal of Global Oncology, Vol 4, Pp 1-4 (2016)
Autor:
Nikihil Pandey, Ashay Karpe, Tushar Vora, Jaya Ghosh, Ashish Singh, Bharat Rekhi, Vikas Talreja, Arun Chandrasekharan, Jyoti Bajpai, Sudeep Gupta, Vijai Simha, Shripad Banavali
Publikováno v:
Journal of Global Oncology, Vol 4, Iss 1, Pp 1-10 (2018)
Journal of Global Oncology
Journal of Global Oncology
Purpose Metastatic osteosarcoma is largely treated with high-dose methotrexate (HDMTX)–based therapy, especially in the pediatric population. This mandates complex pharmacokinetic monitoring in a costly inpatient setting to mitigate unpredictable s